# Neuralink — Healthcare Investment Intelligence

> medical_device · Series C+. MedFuel Intel profile as of 2026-06-12.

Neuralink is developing implantable brain-computer interfaces (BCIs) with high channel counts for motor control and other functions, having received FDA approval for human clinical trials and completed the first human implant.[1][4][5] The company, founded in 2016 by Elon Musk, has raised multiple funding rounds beyond Series C, including significant investments supporting advanced preclinical and clinical progress.[1]

## Key facts (as of 2026-06-12)
- Sector: medical_device
- Stage: Series C+
- Website: https://neuralink.com

## MedFuel assessment
- Intelligence score: 0/100
- Analyses: 0
- Sentiment trend: stable

---
Source: MedFuel Intel — https://medfuelintel.com/company/neuralink-24. Figures reflect MedFuel's analysis; verify against primary sources (SEC, FDA, ClinicalTrials.gov) before any investment decision.